NovoCure Ltd (NVCR)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 70M 140M 210M Q3 '21: 133.6M Q4 '21: 133.2M Q1 '22: 137.5M Q2 '22: 140.9M Q3 '22: 131M Q4 '22: 128.4M Q1 '23: 122.2M Q2 '23: 126.1M Q3 '23: 127.3M Q4 '23: 133.8M Q1 '24: 138.5M Q2 '24: 150.4M Q3 '24: 155.1M Q4 '24: 161.3M Q1 '25: 155M Q2 '25: 158.8M Q3 '25: 167.2M Q4 '25: 174.3M Q1 '26: 174.1M Q2 '26: 183.6M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit Quarterly

0 50M 100M 150M Q3 '21: 103.4M Q4 '21: 103.5M Q1 '22: 109.8M Q2 '22: 112.4M Q3 '22: 101.2M Q4 '22: 99.5M Q1 '23: 92.6M Q2 '23: 92M Q3 '23: 95.2M Q4 '23: 101.2M Q1 '24: 104.8M Q2 '24: 115.7M Q3 '24: 119.7M Q4 '24: 127.8M Q1 '25: 116.5M Q2 '25: 117.3M Q3 '25: 122.5M Q4 '25: 132.2M Q1 '26: 135.1M Q2 '26: 142.5M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income Quarterly

-75M -50M -25M 0 25M 50M 75M Q3 '21: -8.6M Q4 '21: -23.4M Q1 '22: -806K Q2 '22: -21.1M Q3 '22: -24.6M Q4 '22: -43M Q1 '23: -60.2M Q2 '23: -62.7M Q3 '23: -58.2M Q4 '23: -51.7M Q1 '24: -41.5M Q2 '24: -33.6M Q3 '24: -32.1M Q4 '24: -63.3M Q1 '25: -37.9M Q2 '25: -39.5M Q3 '25: -36M Q4 '25: -40.4M Q1 '26: -67.4M Q2 '26: -10.6M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

-75M -50M -25M 0 25M 50M 75M Q3 '21: -13.1M Q4 '21: -26.5M Q1 '22: -4.6M Q2 '22: -24M Q3 '22: -26.6M Q4 '22: -37.3M Q1 '23: -53.1M Q2 '23: -57.4M Q3 '23: -49.5M Q4 '23: -47.1M Q1 '24: -38.8M Q2 '24: -33.4M Q3 '24: -30.6M Q4 '24: -65.9M Q1 '25: -34.3M Q2 '25: -40.1M Q3 '25: -37.3M Q4 '25: -24.5M Q1 '26: -71.1M Q2 '26: -15.7M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

0 20M 40M 60M Q3 '21: 30.2M Q4 '21: 29.7M Q1 '22: 27.7M Q2 '22: 28.5M Q3 '22: 29.7M Q4 '22: 28.9M Q1 '23: 29.6M Q2 '23: 34M Q3 '23: 32.1M Q4 '23: 32.6M Q1 '24: 33.7M Q2 '24: 34.7M Q3 '24: 35.4M Q4 '24: 33.5M Q1 '25: 38.5M Q2 '25: 41.5M Q3 '25: 44.7M Q4 '25: 42.2M Q1 '26: 38.9M Q2 '26: 41.1M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow Quarterly

-45M -30M -15M 0 15M 30M 45M Q3 '21: 24.4M Q4 '21: 14.4M Q1 '22: -3.7M Q2 '22: 15.8M Q3 '22: 22.4M Q4 '22: -3.7M Q1 '23: -16.7M Q2 '23: -22.7M Q3 '23: -19.3M Q4 '23: -14.6M Q1 '24: -31.6M Q2 '24: -1.7M Q3 '24: 10.4M Q4 '24: -3.5M Q1 '25: -35.7M Q2 '25: -15.9M Q3 '25: 20.6M Q4 '25: -18M Q1 '26: -13.5M Q2 '26: 8.1M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-60M -40M -20M 0 20M 40M 60M Q3 '21: 21.1M Q4 '21: 130K Q1 '22: -8.8M Q2 '22: 11.6M Q3 '22: 16.7M Q4 '22: -10.1M Q1 '23: -22.8M Q2 '23: -29.7M Q3 '23: -26.6M Q4 '23: -21.4M Q1 '24: -43.4M Q2 '24: -13.2M Q3 '24: -307K Q4 '24: -12.4M Q1 '25: -46.3M Q2 '25: -21.4M Q3 '25: 14.9M Q4 '25: -22.9M Q1 '26: -18.7M Q2 '26: 1.2M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 40M 80M 120M Q4 '20: 110.6M Q1 '21: 102.6M Q2 '21: 103.5M Q3 '21: 103.7M Q4 '21: 103.9M Q1 '22: 104.2M Q2 '22: 104.6M Q3 '22: 104.9M Q4 '22: 105M Q1 '23: 105.7M Q2 '23: 106.3M Q3 '23: 106.8M Q1 '24: 107.3M Q2 '24: 107.7M Q3 '24: 108.2M Q1 '25: 110.3M Q2 '25: 111.6M Q3 '25: 111.9M Q1 '26: 114.1M Q2 '26: 116M Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-2.10 -1.40 -0.70 0.00 0.70 1.40 2.10 Q3 '21: -0.27 Q4 '21: -0.56 Q1 '22: -0.56 Q2 '22: -0.65 Q3 '22: -0.77 Q4 '22: -0.88 Q1 '23: -1.34 Q2 '23: -1.65 Q3 '23: -1.86 Q4 '23: -1.94 Q1 '24: -1.80 Q2 '24: -1.57 Q3 '24: -1.39 Q4 '24: -1.56 Q1 '25: -1.51 Q2 '25: -1.56 Q3 '25: -1.61 Q4 '25: -1.22 Q1 '26: -1.53 Q2 '26: -1.30 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.